{"disease":{"id":"congenital-adrenal-hyperplasia-cah","name":"congenital adrenal hyperplasia cah"},"drugs":{"marketed":[{"drug_id":"crinecerfont","indication_name":"classic congenital adrenal hyperplasia (CAH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crenessity","generic_name":"CRINECERFONT","company_name":"Neurocrine","drug_phase":"marketed","molecular_target":"","drug_class":"Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Crenessity blocks the hormone corticotropin-releasing factor, which stimulates the adrenal glands to produce excess hormones."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00250159","title":"Natural History Study of Patients With Excess Androgen","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT00001521","title":"Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":true},{"nct_id":"NCT07099456","title":"Fertility And Sexual Function In CAH: CALLIOPE","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Roma La Sapienza","has_results":false},{"nct_id":"NCT03550261","title":"Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07473804","title":"Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03257462","title":"Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Spruce Biosciences","has_results":true},{"nct_id":"NCT03687242","title":"Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Spruce Biosciences","has_results":true},{"nct_id":"NCT01859312","title":"Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}